SK282570B6 - Antagonisty progesterónu na výrobu liekov na ošetrenie dysfunkčného maternicového krvácania - Google Patents
Antagonisty progesterónu na výrobu liekov na ošetrenie dysfunkčného maternicového krvácania Download PDFInfo
- Publication number
- SK282570B6 SK282570B6 SK1219-96A SK121996A SK282570B6 SK 282570 B6 SK282570 B6 SK 282570B6 SK 121996 A SK121996 A SK 121996A SK 282570 B6 SK282570 B6 SK 282570B6
- Authority
- SK
- Slovakia
- Prior art keywords
- hydroxy
- treatment
- bleeding
- estradien
- progesterone antagonists
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP1995/000394 WO1996023503A1 (de) | 1995-02-02 | 1995-02-02 | Progesteronantagonisten für die herstellung von arzneimitteln zur behandlung von dysfunktionellen uterinen blutungen |
Publications (2)
Publication Number | Publication Date |
---|---|
SK121996A3 SK121996A3 (en) | 1997-05-07 |
SK282570B6 true SK282570B6 (sk) | 2002-10-08 |
Family
ID=8165951
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1219-96A SK282570B6 (sk) | 1995-02-02 | 1995-02-02 | Antagonisty progesterónu na výrobu liekov na ošetrenie dysfunkčného maternicového krvácania |
Country Status (20)
Country | Link |
---|---|
US (1) | US6451780B1 (ja) |
EP (1) | EP0806952B1 (ja) |
JP (1) | JPH10512889A (ja) |
KR (1) | KR100370908B1 (ja) |
AT (1) | ATE235907T1 (ja) |
AU (1) | AU714959B2 (ja) |
CA (1) | CA2186953C (ja) |
DE (1) | DE59510626D1 (ja) |
DK (1) | DK0806952T3 (ja) |
ES (1) | ES2196063T3 (ja) |
FI (1) | FI117850B (ja) |
HU (1) | HU226276B1 (ja) |
MX (1) | MX9603889A (ja) |
NO (1) | NO964155L (ja) |
NZ (1) | NZ287024A (ja) |
PL (1) | PL316533A1 (ja) |
PT (1) | PT806952E (ja) |
SK (1) | SK282570B6 (ja) |
UA (1) | UA37259C2 (ja) |
WO (1) | WO1996023503A1 (ja) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RO122179B1 (ro) | 1999-08-31 | 2009-02-27 | Schering Aktiengesellschaft | Utilizarea de mezoprogestine pentru tratamentul şi prevenirea afecţiunilor ginecologice benigne, hormon-dependente |
US8193252B1 (en) * | 1999-08-31 | 2012-06-05 | Bayer Pharma AG | Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders |
US6685626B2 (en) | 2001-02-02 | 2004-02-03 | Regeneration Technologies, Inc. | Compositions, devices, methods, and kits for induction of adhesions |
US20020176893A1 (en) * | 2001-02-02 | 2002-11-28 | Wironen John F. | Compositions, implants, methods, and kits for closure of lumen openings, repair of ruptured tissue, and for bulking of tissue |
US20080182841A1 (en) * | 2001-10-29 | 2008-07-31 | Levine Howard L | Vaginally administered anti-dysrhythmic agents for treating pelvic pain |
EP1761231A1 (en) * | 2004-06-07 | 2007-03-14 | Duramed Pharmaceuticals, Inc. | Dispenser for progestin used for acute and maintenance treatment of dub |
WO2007103510A2 (en) * | 2006-03-08 | 2007-09-13 | Danco Laboratories Llc | Methods, dosing regimens & medications using anti-progestational agents for the treatment of disorders |
CA2684450C (en) * | 2007-04-20 | 2017-05-30 | Preglem S.A. | Progesterone antagonist and selective progesterone modulator in the treatment of excessive uterine bleeding |
US20090118253A1 (en) * | 2007-11-05 | 2009-05-07 | Repros Therapeutics Inc. | Compositions and methods for treating dysfunctional uterine bleeding |
US12011423B2 (en) | 2007-11-06 | 2024-06-18 | Foraviset Ltd. | S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders |
US8299050B2 (en) * | 2008-01-29 | 2012-10-30 | Laboratoire Hra-Pharma | Method for treating uterine fibroids |
TWI539953B (zh) * | 2008-04-28 | 2016-07-01 | 瑞波若斯治療學公司 | 用於治療乳癌之組成物和方法 |
TWI477276B (zh) * | 2008-04-28 | 2015-03-21 | Repros Therapeutics Inc | 抗黃體素給藥方案 |
DE102009034367A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten |
DE102009034366A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
DE102009034368A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
DE102009034526A1 (de) | 2009-07-21 | 2011-02-10 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten |
DE102010007719A1 (de) | 2010-02-10 | 2011-08-11 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Progesteronrezeptorantagonisten |
DE102010007722A1 (de) | 2010-02-10 | 2011-08-11 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Progesteronrezeptorantagonisten |
EP2545922A1 (en) * | 2011-07-12 | 2013-01-16 | PregLem S.A. | Treatment of excessive menstrual bleeding associated with uterine fibroids |
SG10201704858PA (en) | 2012-05-31 | 2017-07-28 | Repros Therapeutics Inc | Formulations and methods for vaginal delivery of antiprogestins |
MX2015004821A (es) | 2012-11-02 | 2015-08-14 | Repros Therapeutics Inc | Metodos y composiciones para tratar condiciones dependientes de la progesterona. |
WO2017112904A1 (en) | 2015-12-23 | 2017-06-29 | Oric Pharmaceuticals, Inc. | Inhibitors of glucocorticoid receptor |
AU2016377702B2 (en) | 2015-12-23 | 2021-03-11 | Oric Pharmaceuticals, Inc. | Inhibitors of glucocorticoid receptor |
US11208432B2 (en) | 2015-12-23 | 2021-12-28 | Oric Pharmaceuticals, Inc. | Inhibitors of glucocorticoid receptor |
CN111690031B (zh) | 2016-10-07 | 2021-06-01 | 欧瑞克制药公司 | 糖皮质激素受体抑制剂 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5622943A (en) | 1992-05-06 | 1997-04-22 | The Medical College Of Hampton Roads | Minimizing progestin associated breakthrough bleeding |
WO1993021926A1 (en) * | 1992-05-06 | 1993-11-11 | Medical College Of Hampton Roads | Minimizing progestin associated breakthrough bleeding |
-
1995
- 1995-02-02 ES ES95919986T patent/ES2196063T3/es not_active Expired - Lifetime
- 1995-02-02 DE DE59510626T patent/DE59510626D1/de not_active Expired - Lifetime
- 1995-02-02 WO PCT/EP1995/000394 patent/WO1996023503A1/de active IP Right Grant
- 1995-02-02 CA CA002186953A patent/CA2186953C/en not_active Expired - Lifetime
- 1995-02-02 AT AT95919986T patent/ATE235907T1/de active
- 1995-02-02 KR KR1019960705470A patent/KR100370908B1/ko not_active IP Right Cessation
- 1995-02-02 MX MX9603889A patent/MX9603889A/es not_active IP Right Cessation
- 1995-02-02 EP EP95919986A patent/EP0806952B1/de not_active Expired - Lifetime
- 1995-02-02 AU AU25611/95A patent/AU714959B2/en not_active Ceased
- 1995-02-02 PT PT95919986T patent/PT806952E/pt unknown
- 1995-02-02 UA UA96104324A patent/UA37259C2/uk unknown
- 1995-02-02 JP JP8523189A patent/JPH10512889A/ja not_active Withdrawn
- 1995-02-02 DK DK95919986T patent/DK0806952T3/da active
- 1995-02-02 SK SK1219-96A patent/SK282570B6/sk unknown
- 1995-02-02 PL PL95316533A patent/PL316533A1/xx unknown
- 1995-02-02 HU HU9602668A patent/HU226276B1/hu not_active IP Right Cessation
-
1996
- 1996-08-01 FI FI963049A patent/FI117850B/fi not_active IP Right Cessation
- 1996-10-01 NZ NZ287024A patent/NZ287024A/en not_active IP Right Cessation
- 1996-10-01 NO NO964155A patent/NO964155L/no not_active Application Discontinuation
-
2000
- 2000-07-12 US US09/615,060 patent/US6451780B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU2561195A (en) | 1996-08-21 |
NO964155D0 (no) | 1996-10-01 |
CA2186953A1 (en) | 1996-08-08 |
FI963049A0 (fi) | 1996-08-01 |
PL316533A1 (en) | 1997-01-20 |
UA37259C2 (uk) | 2001-05-15 |
HUT75930A (en) | 1997-05-28 |
SK121996A3 (en) | 1997-05-07 |
PT806952E (pt) | 2003-08-29 |
FI117850B (fi) | 2007-03-30 |
ES2196063T3 (es) | 2003-12-16 |
HU226276B1 (en) | 2008-07-28 |
EP0806952B1 (de) | 2003-04-02 |
HU9602668D0 (en) | 1996-11-28 |
EP0806952A1 (de) | 1997-11-19 |
DK0806952T3 (da) | 2003-06-16 |
KR970704451A (ko) | 1997-09-06 |
WO1996023503A1 (de) | 1996-08-08 |
AU714959B2 (en) | 2000-01-13 |
JPH10512889A (ja) | 1998-12-08 |
KR100370908B1 (ko) | 2003-04-10 |
ATE235907T1 (de) | 2003-04-15 |
MX9603889A (es) | 1997-04-30 |
NZ287024A (en) | 2001-03-30 |
DE59510626D1 (de) | 2003-05-08 |
CA2186953C (en) | 2009-11-10 |
NO964155L (no) | 1996-10-01 |
US6451780B1 (en) | 2002-09-17 |
FI963049A (fi) | 1996-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK282570B6 (sk) | Antagonisty progesterónu na výrobu liekov na ošetrenie dysfunkčného maternicového krvácania | |
USRE43916E1 (en) | Composition for contraception | |
US5898032A (en) | Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy | |
US5633242A (en) | Pharmaceuticals for contraception/hormone substitution containing a biogenous estrogen component | |
KR100365879B1 (ko) | 프로게스테론길항제및게스타겐을포함하는자궁내막증식증또는자궁평활근종치료제 | |
RU2165258C2 (ru) | Фармацевтический комбинированный препарат для гормональной контрацепции | |
JPH09510183A (ja) | 複合避妊薬 | |
SK178097A3 (en) | Pharmaceutical combined preparation, kit and method for hormonal contraception | |
CA2241192A1 (en) | Contraceptive process and kit for female mammals that consists of a combination of gestagen and estrogen | |
AU707235B2 (en) | Competitive progesterone antagonists for demand-oriented female birth control | |
US20030018018A1 (en) | Ultra low dose oral contraceptives with sustained efficacy and induced amenorrhea | |
WO1999025360A2 (en) | Progestogen-antiprogestogen regimens | |
RU2170580C2 (ru) | Антагонисты прогестерона для получения лекарств при лечении дисфункциональных маточных кровотечений | |
CZ284596A3 (en) | Progesterone antagonists for preparing medicaments applied for treating dysfunctional uterine bleeding | |
Kovacs | Luteal contraception | |
DE4403769A1 (de) | Progesteronantagonisten für die Herstellung von Arzneimitteln zur Behandlung von dysfunktionellen uterinen Blutungen | |
ZA200201614B (en) | Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives. | |
CA2596416A1 (en) | Methods of extended use oral contraception |